Singular Health (Australia) Performance
| SHG Stock | 0.11 0.01 8.33% |
On a scale of 0 to 100, Singular Health holds a performance score of 10. The entity has a beta of -0.25, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Singular Health are expected to decrease at a much lower rate. During the bear market, Singular Health is likely to outperform the market. Please check Singular Health's total risk alpha, treynor ratio, value at risk, as well as the relationship between the sortino ratio and maximum drawdown , to make a quick decision on whether Singular Health's existing price patterns will revert.
Risk-Adjusted Performance
10 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Singular Health Group are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain technical and fundamental indicators, Singular Health unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Singular Health Expands U.S. Reach and AI Integration - TipRanks | 10/31/2024 |
2 | Singular Health Partners with PNS for 3Dicom Rollout - TipRanks | 11/19/2024 |
| Begin Period Cash Flow | 691.5 K | |
| Free Cash Flow | -2.5 M |
Singular |
Singular Health Relative Risk vs. Return Landscape
If you would invest 8.00 in Singular Health Group on September 2, 2024 and sell it today you would earn a total of 3.00 from holding Singular Health Group or generate 37.5% return on investment over 90 days. Singular Health Group is generating 0.5753% of daily returns assuming 4.3862% volatility of returns over the 90 days investment horizon. Simply put, 39% of all stocks have less volatile historical return distribution than Singular Health, and 89% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Singular Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Singular Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Singular Health Group, and traders can use it to determine the average amount a Singular Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1312
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | SHG | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.39 actual daily | 39 61% of assets are more volatile |
Expected Return
| 0.58 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Singular Health is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Singular Health by adding it to a well-diversified portfolio.
Singular Health Fundamentals Growth
Singular Stock prices reflect investors' perceptions of the future prospects and financial health of Singular Health, and Singular Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Singular Stock performance.
| Return On Equity | -3.83 | ||||
| Return On Asset | -0.72 | ||||
| Operating Margin | (3.31) % | ||||
| Current Valuation | 25.44 M | ||||
| Shares Outstanding | 242.52 M | ||||
| Price To Book | 18.51 X | ||||
| Price To Sales | 28.56 X | ||||
| Revenue | 90.83 K | ||||
| Gross Profit | (71.87 K) | ||||
| EBITDA | (2.89 M) | ||||
| Net Income | (2.88 M) | ||||
| Total Debt | 218.45 K | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (2.44 M) | ||||
| Earnings Per Share | (0.02) X | ||||
| Total Asset | 2.35 M | ||||
| Retained Earnings | (20.9 M) | ||||
About Singular Health Performance
Assessing Singular Health's fundamental ratios provides investors with valuable insights into Singular Health's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Singular Health is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Singular Health is entity of Australia. It is traded as Stock on AU exchange.Things to note about Singular Health Group performance evaluation
Checking the ongoing alerts about Singular Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Singular Health Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Singular Health has some characteristics of a very speculative penny stock | |
| Singular Health appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 90.83 K. Net Loss for the year was (2.88 M) with loss before overhead, payroll, taxes, and interest of (71.87 K). | |
| Singular Health generates negative cash flow from operations | |
| About 45.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Singular Health Partners with PNS for 3Dicom Rollout - TipRanks |
- Analyzing Singular Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Singular Health's stock is overvalued or undervalued compared to its peers.
- Examining Singular Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Singular Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Singular Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Singular Health's stock. These opinions can provide insight into Singular Health's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Singular Stock Analysis
When running Singular Health's price analysis, check to measure Singular Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Singular Health is operating at the current time. Most of Singular Health's value examination focuses on studying past and present price action to predict the probability of Singular Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Singular Health's price. Additionally, you may evaluate how the addition of Singular Health to your portfolios can decrease your overall portfolio volatility.